Found: 17
Select item for more details and to access through your institution.
IgE-Mediated Cannabis Allergy and Cross-Reactivity Syndromes: A Roadmap for Correct Diagnosis and Management.
- Published in:
- Current Allergy & Asthma Reports, 2024, v. 24, n. 8, p. 407, doi. 10.1007/s11882-024-01159-5
- By:
- Publication type:
- Article
Mas-related G protein-coupled receptor MRGPRX2 in human basophils: Expression and functional studies.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1026304
- By:
- Publication type:
- Article
Overexpression of FcεRI on Bone Marrow Mast Cells, but Not MRGPRX2, in Clonal Mast Cell Disorders With Wasp Venom Anaphylaxis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.835618
- By:
- Publication type:
- Article
Correspondence to "Basophil activation test as predictor of severity and threshold of allergic reactions to egg".
- Published in:
- Allergy, 2024, v. 79, n. 5, p. 1386, doi. 10.1111/all.15950
- By:
- Publication type:
- Article
Correspondence to "Diagnosis of immediate reactions to amoxicillin: Comparison of basophil activation markers CD63 and CD203c in a prospective study".
- Published in:
- Allergy, 2023, v. 78, n. 10, p. 2808, doi. 10.1111/all.15686
- By:
- Publication type:
- Article
Letter to the Authors Concerning the Published Manuscript by Rial and Sastre: Food Allergies Caused by Allergenic Lipid Transfer Proteins: What Is Behind the Geographic Restriction?
- Published in:
- Current Allergy & Asthma Reports, 2018, v. 18, n. 12, p. 1, doi. 10.1007/s11882-018-0828-0
- By:
- Publication type:
- Article
Mast cell versus basophil activation test in allergy: Current status.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 6, p. 378, doi. 10.1111/cea.14487
- By:
- Publication type:
- Article
Dual intracellular staining of CD154 (CD40L) and cytokines at single‐cell level: A novel aid to document immediate hypersensitivity to amoxicillin.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 6, p. 679, doi. 10.1111/cea.14313
- By:
- Publication type:
- Article
Mast cell activation test: A new asset in the investigation of the chlorhexidine cross‐sensitization profile.
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 11, p. 1311, doi. 10.1111/cea.14129
- By:
- Publication type:
- Article
Tryptase release does not discriminate between IgE‐ and MRGPRX2‐mediated activation in human mast cells.
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 6, p. 797, doi. 10.1111/cea.14110
- By:
- Publication type:
- Article
Mast cell activation tests by flow cytometry: A new diagnostic asset?
- Published in:
- Clinical & Experimental Allergy, 2021, v. 51, n. 11, p. 1482, doi. 10.1111/cea.13984
- By:
- Publication type:
- Article
Basophil activation test in the diagnosis of hypersensitivity reactions to quinolones by Loli‐Ausejo et al.
- Published in:
- Clinical & Experimental Allergy, 2021, v. 51, n. 7, p. 980, doi. 10.1111/cea.13853
- By:
- Publication type:
- Article
CD154 (CD40L): A novel aid to document nonimmediate hypersensitivity to amoxicillin or amoxicillin clavulanic acid.
- Published in:
- Clinical & Experimental Allergy, 2020, v. 50, n. 5, p. 640, doi. 10.1111/cea.13581
- By:
- Publication type:
- Article
In vitro Diagnosis of Immediate Drug Hypersensitivity: Should We Go with the Flow?
- Published in:
- International Archives of Allergy & Immunology, 2015, v. 168, n. 1, p. 3, doi. 10.1159/000440663
- By:
- Publication type:
- Article
Prevalence of self‐reported and confirmed penicillin allergy in a Belgian outpatient population.
- Published in:
- Allergy, 2020, v. 75, n. 8, p. 1, doi. 10.1111/all.14292
- By:
- Publication type:
- Article
Performance of basophil activation test and specific IgG4 as diagnostic tools in nonspecific lipid transfer protein allergy: Antwerp‐Barcelona comparison.
- Published in:
- Allergy, 2020, v. 75, n. 3, p. 616, doi. 10.1111/all.14040
- By:
- Publication type:
- Article
Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.668962
- By:
- Publication type:
- Article